COc1cc(C#Cc2c(-c3cncn3C)n(C)c3ccc(-c4ccc5cc[nH]c5c4)cc23)cc(OC)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?